Single cell whole genome sequencing of high hyperdiploid acute lymphoblastic leukemia
This dataset included 577 samples with high hyperdiploid acute lymphoblastic leukemia (ALL) that were collected from four different cohorts: the Division of Clinical Genetics, Lund University, Sweden, Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic (Zaliova et al., 2016), Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France (Duployez et al., 2018), and The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) program (NCBI dbGAP accession number phs00464). All samples were genotyped using either the Affymetrix SNP Array, Illumina's BeadArray platform or the whole genome/exome sequencing by the Illumina platform.
Nine high hyperdiploid ALL samples and one normal bone marrow sample were subjected to low pass single cell whole genome sequencing with the median sequencing coverage of 0.02x. Single nuclei in G0/G1 phase were isolated using a fluorescence-activated cell sorting (FACS) cytometer. DNA libraries were constructed and associated next-generation sequencing was carried out by European Research Institute for the Biology of Ageing (ERIBA), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Further details regarding the DNA libraries construction are available by Bos et. al., 2019 (https://link.springer.com/protocol/10.1007/978-1-4939-8931-7_15). The dataset has been used for copy number aberrations analysis.
The raw SNP array data and bulk WGS data are available from the corresponding authors upon request
Cite items from this project
The role of CTCF and cohesin in leukemia developmentSwedish Research CouncilFind out more...
Genetic and epigenetic studies of pediatric acute leukemiaSwedish Research CouncilFind out more...
Swedish Childhood Cancer Foundation(PR2018-0023, PR2020-0033, and TJ2020-0024)
Swedish Cancer Fund (19-0252-Pj)
Governmental funding of clinical research within the National Health Service (ALFSKANE-623431)
Gunnar Nilsson Cancer Foundation (GN-2020-9 -(190))
The Royal Physiographic Society of Lund